Scot Harper
Technik-/Wissenschafts-/F&E-Leiter bei RADIOPHARM THERANOSTICS LIMITED
Aktive Positionen von Scot Harper
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 | - |
Karriereverlauf von Scot Harper
Ehemalige bekannte Positionen von Scot Harper
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENDOCYTE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 07.05.2013 | 28.10.2016 |
| Corporate Officer/Principal | 07.05.2013 | 14.05.2014 |
Ausbildung von Scot Harper
| University of South Alabama | Graduate Degree |
| DePauw University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Australien | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private Unternehmen | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Börse
- Insiders
- Scot Harper
- Erfahrung